Unison Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 04-12-2024
- Paid Up Capital ₹ 8.81 Cr
as on 04-12-2024
- Company Age 23 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 70.29 Cr
as on 04-12-2024
- Revenue 24.02%
(FY 2022)
- Profit 0.13%
(FY 2022)
- Ebitda -0.82%
(FY 2022)
- Net Worth 13.83%
(FY 2022)
- Total Assets 3.24%
(FY 2022)
About Unison Pharmaceuticals
The Corporate was formerly known as Unison Pharmaceutical Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 8.81 Cr.
The company currently has active open charges totaling ₹70.29 Cr.
Nitin Shah and Bhagyesh Shah serve as directors at the Company.
- CIN/LLPIN
U24232GJ2001PTC079092
- Company No.
079092
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Jun 2001
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Unison Pharmaceuticals Private Limited offer?
Unison Pharmaceuticals Private Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Cholesterol Medicine, Brain & Nervous System Drugs, Antidepressant & Anti Anxiety Medicines, Common Disease Medicines, Steroid, Health Conditions, Bone, Joint & Muscle Care.
Who are the key members and board of directors at Unison Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhagyesh Shah  | Managing Director | 27-Oct-2013 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nitin Shah | Director | 27-Oct-2013 | Current |
Financial Performance of Unison Pharmaceuticals.
Unison Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 24.02% increase. The company also saw a slight improvement in profitability, with a 0.13% increase in profit. The company's net worth Soared by an impressive increase of 13.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Unison Pharmaceuticals?
In 2022, Unison Pharmaceuticals had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Cosmecia Healthcare Private LimitedActive 3 months 26 days
Nitin Shah and Bhagyesh Shah are mutual person
- Unison Remedies Private LimitedActive 12 years 2 months
Nitin Shah and Bhagyesh Shah are mutual person
- Unison Bioscience Private LimitedActive 12 years 29 days
Nitin Shah and Bhagyesh Shah are mutual person
- Unison Life Sciences Private LimitedActive 12 years 2 months
Nitin Shah and Bhagyesh Shah are mutual person
- Unison Nutraceuticals Private LimitedActive 11 years 2 months
Nitin Shah and Bhagyesh Shah are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 27 Aug 2020 | ₹2.90 M | Open |
Hdfc Bank Limited Creation Date: 03 Aug 2015 | ₹35.00 Cr | Open |
Hdfc Bank Limited Creation Date: 31 Jul 2015 | ₹35.00 Cr | Open |
How Many Employees Work at Unison Pharmaceuticals?
Unison Pharmaceuticals has a workforce of 1044 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Unison Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unison Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
